ArticleBiotechnology letters2025
Heterologous expression of flavohemoglobin in Rhodotorula toruloides led to improved lipid production.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The red yeast Rhodotorula toruloides emerged as a prominent host for microbial lipid production. It has been known that oxygen supply is a limiting factor for de novo lipid biosynthesis especially under high cell-density culture conditions. Bacterial hemoglobin is an oxygen-binding protein that can actively transport oxygen from the environment to metabolic processes. The aim of the present study was to address the problem of oxygen limitation during R. toruloides culture thereby enhancing cell growth and lipid synthesis. Thus, genes encoding flavohemoglobin (SHb) from Sinorhizobium meliloti and hemoglobin (VHb) from Vitreoscilla sp. were separately integrated into the genome of R. toruloides CGMCC 2.1389 by Agrobacterium-mediated transformation method. It was found that the engineered strain 4S-8 with SHB gene integration produced 49% more lipids under shake-flask culture condition than the parent strain. Under the two-stage culture process, the engineered strain 4S-8 produced 23% and 10% more cell mass than the parent strain and the strain 4V-10 with VHB gene integration, respectively, while the lipid titer of strain 4S-8 was 42% higher than that of the parent strain. These results suggested that heterologous expression of SHb in oleaginous hosts may be applicable for improved production of lipids and cell mass, which should facilitate more efficient conversion of sugars into lipids and fatty-acid derived biofuels.
Indexed as
Identifiers
40418250What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.